Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be reporting earnings this Tuesday morning. Here’s what investors should know.
Quest beat analysts’ revenue expectations by 1.3% last quarter, reporting revenues of $2.65 billion, up 12.1% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts’ sales volume estimates but full-year EPS guidance in line with analysts’ estimates.
Is Quest a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Quest’s revenue to grow 13.6% year on year to $2.72 billion, improving from the 2.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.57 per share.
Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 7 downward revisions over the last 30 days (we track 12 analysts). Quest has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 1.9% on average.
Looking at Quest’s peers in the healthcare providers & services segment, only Elevance Health has reported results so far. It beat analysts’ revenue estimates by 3%, delivering year-on-year sales growth of 13.4%. The stock was down 19.7% on the results.
Read our full analysis of Elevance Health’s earnings results here.Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.3% on average over the last month. Quest is down 7.1% during the same time and is heading into earnings with an average analyst price target of $184.04 (compared to the current share price of $166.91).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.